Validation of CPS+EG, Neo-Bioscore, and modified Neo-Bioscore staging systems after preoperative systemic therapy of breast cancer: Protocol of a retrospective multicenter cohort study in China

about

Validation of CPS+EG, Neo-Bioscore, and modified Neo-Bioscore staging systems after preoperative systemic therapy of breast cancer: Protocol of a retrospective multicenter cohort study in China

Item

http://www.wikidata.org/entity/Q57192072

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Validation of CPS+EG, Neo-Bios ...... ticenter cohort study in China

@en

Validation of CPS+EG, Neo-Bios ...... ticenter cohort study in China

@nl

type

Item

label

Validation of CPS+EG, Neo-Bios ...... ticenter cohort study in China

@en

Validation of CPS+EG, Neo-Bios ...... ticenter cohort study in China

@nl

prefLabel

Validation of CPS+EG, Neo-Bios ...... ticenter cohort study in China

@en

Validation of CPS+EG, Neo-Bios ...... ticenter cohort study in China

@nl

P1476

Validation of CPS+EG, Neo-Bios ...... ticenter cohort study in China

@en

P2093

Bin Zhou

http://www.w3.org/2001/XMLSchema#string

Qian Xiang

http://www.w3.org/2001/XMLSchema#string

Qianxin Liu

http://www.w3.org/2001/XMLSchema#string

Sainan Zhu

http://www.w3.org/2001/XMLSchema#string

Xuening Duan

http://www.w3.org/2001/XMLSchema#string

Yinhua Liu

http://www.w3.org/2001/XMLSchema#string

Zhuo Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized

Breast cancer prognostic classification in the molecular era: the role of histological grade.

Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study.

P304

1565-1572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1759-7714.12852

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yi-Min Cui

Ling Xu

P577

2018-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30296013

http://www.w3.org/2001/XMLSchema#string

P932

6209787

http://www.w3.org/2001/XMLSchema#string